Select Page

Drug Discovery & Screening

Profile compounds and uncover mechanisms-of-action with fluorescent biosensors. Accelerate discovery with flexible, customizable BacMam expression vectors

Precise Tools for Preclinical Discovery

Montana Molecular provides high-resolution, live-cell GPCR signaling assays that go beyond traditional endpoint measurements. Our fluorescent biosensors capture compound behavior in real time, enabling detailed profiling of agonists, antagonists, and modulators across multiple pathways – cAMP, DAG, calcium, and arrestin recruitment.

BacMam-mediated delivery of biosensors and therapeutic targets enables tunable expression, efficient transduction across diverse cell types, and multi-species profiling – supporting rapid assay optimization and translational study design.

We also offer comprehensive compound profiling services and custom BacMam vector solutions, providing presentation-quality data and expression tools tailored to meet the specific needs of your research.

Kinetic GPCR Signaling Assays

While traditional endpoint assays provide a single data point, our live-cell fluorescent biosensors deliver a high-resolution view of signaling events. By monitoring responses continuously, you capture the nuances of compound behavior that single-time point assays miss – making these assays ideal for secondary screening and compound characterization. This approach enables detailed profiling of confirmed hits, including signaling kinetics, mechanism-of-action insights, potency and efficacy estimates, and differentiation of compounds based on pathway dynamics and functional selectivity.

 

  • Multipathway readouts: Measure cAMP, DAG, Ca²⁺, and arrestin recruitment responses on a single platform

  • Pharmacological Insights: Waveform analysis of signaling kinetics provides precise estimates of initial response rate, potency, efficacy, signal duration, and receptor desensitization.

  • Detailed Compound Profiling: Accurately characterize and differentiate the activity of agonists, antagonists, partial agonists, and moreall in a single assay.

Figure showing pharmacological data gathered from DAG kinetic signaling

Detecting Persistent Signaling

Measure prolonged signaling using fluorescent biosensors in living cells. The cADDis cAMP sensor enables continuous monitoring of GPCR signaling for up to 24 hours. Download a poster below.

Target Expression with BacMam

Express GPCRs, ion channels, and other therapeutic targets in mammalian cells— across standard screening lines, iPSC-derived, and primary cultures—supporting preclinical drug discovery from HTS through detailed MOA studies.

  • Titratable Expression: Precisely control receptor or target density to match physiological conditions, uncover partial agonists, and explore how density affects EC50.

  • Massive Payload: Deliver large genes, multi-subunit proteins, cell-specific promoters, or multi-gene combinations with a 38kb capacity.

  • Bespoke Solutions: Leverage our expertise to design Custom Bacmam vectors tailored to your experiments – including custom gene expression, species orthologs, splice variants, mutations, fluorescent or genetic tags, multi-gene expression cassettes, or CRISPR/Cas systems.

Save time and resources while harnessing BacMam’s versatile capabilities. Contact our team to create the tools your research requires.

Figure showing pharmacological data gathered from DAG kinetic signaling

Accelerate Your Compound Profiling with Montana Molecular

Montana Molecular specializes in mechanism-of-action pharmacology, using BacMam and in-house biosensor platforms to deliver fast, reliable, and detailed compound analyses.

  • Multi-Species Profiling: Compare activity across human and ortholog targets (mouse, rat, NHP).

  • Kinetic Assays: Continuous-read assays reveal activators, inhibitors, allosteric modulators, bias, and time-dependent effects not observable in endpoint formats.

  • Tunable Receptor Levels: Adjust expression to detect partial agonists and fine-tune signaling sensitivity.

  • Mechanistic Insights: Measure GPCR signaling kinetics, desensitization, and complex multi-step responses—including washout experiments and sequential compound additions—to uncover detailed mechanisms of action.

By leveraging BacMam for rapid assay optimization, Montana Molecular dramatically shortens timelines compared to stable cell lines – delivering presentation-ready results faster.

Figure showing pharmacological data gathered from DAG kinetic signaling

Screening in Disease Relevant Cells

Characterize compounds in living cells relevant to disease, by detecting endogenous or over-expressed receptor signaling. Our assays are packaged in BacMam and have been validated in a wide variety of cell lines, primary cells, and iPSC derived cells – including macrophages, neurons, cardiomyocytes, and pancreatic islets.  Please reach out to us if you would like to test our assays in your cell type, our technical support team is happy to help you get started.

 

cADDis cAMP sensor expressing in primary striatal neurons
cADDis in BrainXell’s iPSC derived motor neurons
cADDis in a pancreatic islet
R-GECO in Ncardia’s Cor.4U 
DAG sensor in Jurkats

Contact Us

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.